Literature DB >> 17325607

Willingness to use microbicides is affected by the importance of product characteristics, use parameters, and protective properties.

Kathleen M Morrow1, Joseph L Fava, Rochelle K Rosen, Sara Vargas, Candelaria Barroso, Anna L Christensen, Cynthia Woodsong, Lawrence Severy.   

Abstract

BACKGROUND: Along with efficacy, a microbicide's acceptability will be integral to its impact on the pandemic. Understanding Product Characteristics that users find most acceptable and determining who will use which type of product are key to optimizing use effectiveness.
OBJECTIVES: To evaluate psychometrically the Important Microbicide Characteristics (IMC) instrument and examine its relationship to willingness to use microbicides.
RESULTS: Exploratory and confirmatory factor analyses revealed 2 IMC subscales (Cronbach's coefficient alpha: Product Characteristics subscale (alpha = 0.84) and Protective Properties subscale (alpha = 0.89)). Significant differences on Product Characteristics subscale scores were found for history of douching (P = 0.002) and employment status (P = 0.001). Whether a woman used a method to prevent pregnancy or sexually transmitted disease (STD) in the last 3 months (P < 0.001) and whether she used a condom during the last vaginal sex episode (P < 0.001) were significantly related to her rating of the importance of microbicides being contraceptive. Product Characteristics (r = 0.21) and Protective Properties (r = 0.27) subscale scores and whether a microbicide had contraceptive properties (r = 0.24) were all significantly associated (P < 0.001) with willingness to use microbicides.
CONCLUSIONS: Formulation and use characteristics and product function(s) affect willingness to use microbicides and should continue to be addressed in product development. The IMC instrument serves as a template for future studies of candidate microbicides.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17325607      PMCID: PMC2628545          DOI: 10.1097/QAI.0b013e3180415ded

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  51 in total

1.  A RATIONALE AND TEST FOR THE NUMBER OF FACTORS IN FACTOR ANALYSIS.

Authors:  J L HORN
Journal:  Psychometrika       Date:  1965-06       Impact factor: 2.500

Review 2.  Covert use of topical microbicides: implications for acceptability and use.

Authors:  Cynthia Woodsong
Journal:  Int Fam Plan Perspect       Date:  2004-06

3.  Women's preferences for vaginal antimicrobial contraceptives. III. Choice of a formulation, applicator, and packaging.

Authors:  E Hardy; A L Jiménez; K S de Pádua; L J Zaneveld
Journal:  Contraception       Date:  1998-10       Impact factor: 3.375

4.  At risk for HIV infection: incarcerated women in a county jail in Philadelphia.

Authors:  L Bond; S Semaan
Journal:  Women Health       Date:  1996

5.  HIV risk behaviors among women living in low-income, inner-city housing developments.

Authors:  K J Sikkema; T G Heckman; J A Kelly; E S Anderson; R A Winett; L J Solomon; D A Wagstaff; R A Roffman; M J Perry; V Cargill; D A Crumble; R W Fuqua; A D Norman; M B Mercer
Journal:  Am J Public Health       Date:  1996-08       Impact factor: 9.308

6.  Female condom use among women at high risk of sexually transmitted disease.

Authors:  M Macaluso; M Demand; L Artz; M Fleenor; L Robey; J Kelaghan; R Cabral; E W Hook
Journal:  Fam Plann Perspect       Date:  2000 May-Jun

7.  Acceptability of a novel vaginal microbicide during a safety trial among low-risk women.

Authors:  M E Bentley; K M Morrow; A Fullem; M A Chesney; S D Horton; Z Rosenberg; K H Mayer
Journal:  Fam Plann Perspect       Date:  2000 Jul-Aug

8.  Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women.

Authors:  Kenneth H Mayer; Salim Abdool Karim; Clifton Kelly; Lisa Maslankowski; Helen Rees; Albert T Profy; Jennifer Day; Julie Welch; Zeda Rosenberg
Journal:  AIDS       Date:  2003-02-14       Impact factor: 4.177

9.  Development of Stage of Readiness and decisional balance instruments: tools to enhance clinical decision-making for adherence to antiretroviral therapy.

Authors:  Gabrielle R Highstein; Cynthia Willey; Linda M Mundy
Journal:  AIDS Behav       Date:  2006-09

10.  The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.

Authors:  Kathleen Morrow; Rochelle Rosen; Linda Richter; Anne Emans; Anna Forbes; Jennifer Day; Neetha Morar; Lisa Maslankowski; Albert T Profy; Cliff Kelly; Salim S Abdool Karim; Kenneth H Mayer
Journal:  J Womens Health (Larchmt)       Date:  2003-09       Impact factor: 2.681

View more
  13 in total

1.  Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties.

Authors:  Kathleen M Morrow; Joseph L Fava; Rochelle K Rosen; Sara Vargas; Julia G Shaw; E Milu Kojic; Patrick F Kiser; David R Friend; David F Katz
Journal:  AIDS Res Hum Retroviruses       Date:  2013-12-09       Impact factor: 2.205

2.  Microbicide acceptability among female sex workers in Beijing, China: results from a pilot study.

Authors:  Lin Han; Fan Lv; Peng Xu; Guolei Zhang; Naomi S Juniper; Zhenglai Wu
Journal:  J Womens Health (Larchmt)       Date:  2009-09       Impact factor: 2.681

3.  User-identified gel characteristics: a qualitative exploration of perceived product efficacy of topical vaginal microbicides.

Authors:  Kathleen M Morrow; Kristen Underhill; Jacob J van den Berg; Sara Vargas; Rochelle K Rosen; David F Katz
Journal:  Arch Sex Behav       Date:  2014-01-23

4.  Measuring self-efficacy to use vaginal microbicides: the Microbicide Use Self-Efficacy instrument.

Authors:  Joseph L Fava; Jacob J van den Berg; Rochelle K Rosen; Liz Salomon; Sara Vargas; Anna L Christensen; Megan Pinkston; Kathleen M Morrow
Journal:  Sex Health       Date:  2013-08       Impact factor: 2.706

5.  Using integrated mixed methods to develop behavioral measures of factors associated with microbicide acceptability.

Authors:  Kathleen M Morrow; Rochelle K Rosen; Liz Salomon; Cynthia Woodsong; Lawrence Severy; Joseph L Fava; Sara Vargas; Candelaria Barroso
Journal:  Qual Health Res       Date:  2011-03-29

6.  Psychometric Properties and Validity of a Multi-dimensional Risk Perception Scale Developed in the Context of a Microbicide Acceptability Study.

Authors:  Sara E Vargas; Joseph L Fava; Lawrence Severy; Rochelle K Rosen; Liz Salomon; Lawrence Shulman; Kate Morrow Guthrie
Journal:  Arch Sex Behav       Date:  2015-11-30

Review 7.  Clinical evaluation of microbicide formulations.

Authors:  Kathleen M Morrow; Craig Hendrix
Journal:  Antiviral Res       Date:  2010-12       Impact factor: 5.970

Review 8.  Designing a multipurpose technology for acceptability and adherence.

Authors:  Elizabeth E Tolley; Kathleen M Morrow; Derek H Owen
Journal:  Antiviral Res       Date:  2013-11-01       Impact factor: 5.970

9.  Effect of acculturation on the acceptability of potential microbicides and sexual risk-taking.

Authors:  Andrea Ries Thurman; Alan E C Holden; Rochelle N Shain; Sondra Perdue; Jeanna M Piper
Journal:  Sex Transm Dis       Date:  2009-06       Impact factor: 2.830

Review 10.  Microbicide clinical trial adherence: insights for introduction.

Authors:  Cynthia Woodsong; Kathleen MacQueen; K Rivet Amico; Barbara Friedland; Mitzy Gafos; Leila Mansoor; Elizabether Tolley; Sheena McCormack
Journal:  J Int AIDS Soc       Date:  2013-04-08       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.